Sars-cov-2-specific antibodies, b cell and t cell immune responses after chadox1 ncov-19 vaccination in solid organ transplant recipients

HIGHLIGHTS

• What: The aim of this study was to assess the immunogenicity of ChAdOx1 nCoV-19 vaccination in SOT The authors conducted an assessment of SARS-CoV-2-specific immune_responses both before the administration of the first vaccine dose and 2-4 weeks after the second dose.
• Who: Pattaraphorn Phornkittikorn et al. from the Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Mahidol University, Bangkok, Thailand have published the paper: SARS-CoV-2-Specific Antibodies, B Cell and T Cell Immune Responses after ChAdOx1 nCoV-19 Vaccination in Solid Organ Transplant Recipients, in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.